GAP for Oncology, Protein-protein Interaction Networks & Drug Screening

Healthcare facility
  • Kuo YL, Chen CH, Chuang TH, Hua WK, Lin WJ, Hsu WH, Chang PMH, Hsu SL, Huang TH, Kao CY*, Huang FCY* (2015), Gene expression profiling and pathway network analysis predicts a novel anti-tumor function for a botanical-derived drug, PG2, Evidence-Based Complementary and Alternative Medicine (eCAM), 2015, Article ID 917345
  • Chen TC, Lin KT, Chen CH, Lee SA, Lee PY, Liu YW, Kuo YL, Wang FS, Lai JM, Huang FCY* (2014), Using an in Situ Proximity Ligation Assay to Systematically Profile Endogenous Protein−Protein Interactions in a Pathway Network, Journal of Proteome Research, 2014, 13, 5339−5346
  • Chen YC, Tien YJ, Chen CH, Beltran FN, Amor EC, Wang RJ, Wu DJ, Mettling C, Lin YL, and Yang WC* (2013). Morus alba and active compound oxyresveratrol exert anti-inflammatory activity via inhibition of leukocyte migration involving MEK/ERK signaling. BMC Complementary and Alternative Medicine, 13:45
  • Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, and Huang FCY (2013). Analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. Molecular and Cellular Proteomics, 12, 1335-1349
  • Kuo YL, Chang MHP, Liu YW, Chen PH, Lee PY, Liu RS, Lai JM, Tien YJ. Wu YC, S, Kao CY, Chen CH*, and Huang FCY* (2012) In silico Therapeutic Drug Screening for Reversing the Lung Adenocarcinoma Overexpressed Gene Signatures. Open Access Scientific Reports, 1: 101. doi:10.4172/scientificreports.101
  • Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chen WJ, Chen JJW, Yang PC* (2007). A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer, The New England Journal of Medicine, 356:11-20
  • Sher YP, Chou CC, Chou RH, Wu HM, Chang WW-S, Chen CH, Wu CW, Yang PC, Yu CL, and Peck K* (2006). Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non–Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness, Cancer Research, 66, 11763-11770
  • Chen JJW, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, and Yang PC* (2005). Tumor-Associated Macrophages: The Double Edged Sword in Cancer Progression, Journal of Clinical Oncology, 23, 1-12